Why is Medinova Diagno. falling/rising?

As of 10-Sep, Medinova Diagnostic Services Ltd is experiencing a decline in its stock price, currently at 41.80, which reflects a decrease of 0.6 or 1.42%. The stock has been underperforming recently, having fallen for three consecutive days with a total return of -2.56% during this period. Despite this short-term decline, the stock has shown positive performance over longer periods, with a 6.06% increase over the past year and a significant 60.77% rise over the last three years. However, the company faces challenges such as a negative book value and weak long-term fundamental strength, which may contribute to investor caution. Additionally, the stock's liquidity has decreased, with delivery volume dropping by 52.19% against the five-day average. In the broader market context, Medinova's recent performance contrasts with the benchmark Sensex, which has gained 1.06% over the past week. While Medinova has outperformed the benchmark in the longer term, its current decline may reflect investor concerns regarding its high debt levels and flat financial results, particularly in light of its poor operating profit growth and low return on capital employed. The combination of these factors suggests that while the stock has historically performed well, its recent price movement may be influenced by underlying financial weaknesses and reduced investor participation.